Wikidata

(Q81851395)

English

A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors

scientific article published on 01 June 2005

In more languages

Statements

title
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15956252
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15956252%20AND%20SRC:MED&resulttype=core&format=json
retrieved
12 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q81851395&oldid=2128144126"